NM_000238.4:c.526C>T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 5P and 5B. PP2PP3_StrongBP6BS2

The NM_000238.4(KCNH2):​c.526C>T​(p.Arg176Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000327 in 1,466,372 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R176G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00032 ( 1 hom. )

Consequence

KCNH2
NM_000238.4 missense

Scores

6
7
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:13B:5O:2

Conservation

PhyloP100: 1.14

Publications

82 publications found
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
KCNH2 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • short QT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • short QT syndrome type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 158 curated pathogenic missense variants (we use a threshold of 10). The gene has 38 curated benign missense variants. Gene score misZ: 3.3724 (above the threshold of 3.09). Trascript score misZ: 2.4846 (below the threshold of 3.09). GenCC associations: The gene is linked to long QT syndrome 2, Brugada syndrome, short QT syndrome type 1, short QT syndrome, long QT syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.964
BP6
Variant 7-150958449-G-A is Benign according to our data. Variant chr7-150958449-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 67509.
BS2
High AC in GnomAd4 at 53 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
NM_000238.4
MANE Select
c.526C>Tp.Arg176Trp
missense
Exon 4 of 15NP_000229.1
KCNH2
NM_001406753.1
c.238C>Tp.Arg80Trp
missense
Exon 2 of 13NP_001393682.1
KCNH2
NM_172056.3
c.526C>Tp.Arg176Trp
missense
Exon 4 of 9NP_742053.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
ENST00000262186.10
TSL:1 MANE Select
c.526C>Tp.Arg176Trp
missense
Exon 4 of 15ENSP00000262186.5
KCNH2
ENST00000713710.1
c.526C>Tp.Arg176Trp
missense
Exon 4 of 15ENSP00000519013.1
KCNH2
ENST00000713701.1
c.226C>Tp.Arg76Trp
missense
Exon 3 of 14ENSP00000519004.1

Frequencies

GnomAD3 genomes
AF:
0.000349
AC:
53
AN:
152020
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000662
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000633
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000324
AC:
25
AN:
77224
AF XY:
0.000270
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00105
Gnomad NFE exome
AF:
0.000656
Gnomad OTH exome
AF:
0.000444
GnomAD4 exome
AF:
0.000324
AC:
426
AN:
1314244
Hom.:
1
Cov.:
32
AF XY:
0.000346
AC XY:
224
AN XY:
647814
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26586
American (AMR)
AF:
0.00
AC:
0
AN:
25522
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23038
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28506
South Asian (SAS)
AF:
0.0000139
AC:
1
AN:
71696
European-Finnish (FIN)
AF:
0.000918
AC:
30
AN:
32688
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4192
European-Non Finnish (NFE)
AF:
0.000367
AC:
384
AN:
1047616
Other (OTH)
AF:
0.000202
AC:
11
AN:
54400
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
23
46
68
91
114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000348
AC:
53
AN:
152128
Hom.:
0
Cov.:
33
AF XY:
0.000282
AC XY:
21
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41538
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.000662
AC:
7
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000633
AC:
43
AN:
67958
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000530
Hom.:
0
Bravo
AF:
0.000215
ExAC
AF:
0.000171
AC:
7

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
4
1
Long QT syndrome 2 (6)
-
2
2
not specified (4)
-
2
1
Long QT syndrome (3)
-
1
1
not provided (3)
-
1
-
Cardiovascular phenotype (1)
-
1
-
Prolonged QT interval (1)
-
1
-
Short QT syndrome type 1 (1)
-
1
-
Short QT syndrome type 1;C3150943:Long QT syndrome 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
CardioboostArm
Benign
0.014
BayesDel_addAF
Uncertain
0.059
T
BayesDel_noAF
Pathogenic
0.23
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.66
D
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.52
D
LIST_S2
Uncertain
0.89
D
M_CAP
Pathogenic
0.68
D
MetaRNN
Pathogenic
0.96
D
MetaSVM
Pathogenic
0.83
D
MutationAssessor
Benign
1.7
L
PhyloP100
1.1
PrimateAI
Pathogenic
0.85
D
PROVEAN
Uncertain
-2.8
D
REVEL
Pathogenic
0.72
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.014
D
Polyphen
1.0
D
Vest4
0.81
MutPred
0.81
Loss of disorder (P = 0.0014)
MVP
0.98
MPC
1.9
ClinPred
0.16
T
GERP RS
0.76
Varity_R
0.067
gMVP
0.54
Mutation Taster
=12/88
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36210422; hg19: chr7-150655537; API